Cancer Research Annual Meeting 2010 Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 59, 5578-5585, November 1, 1999]
© 1999 American Association for Cancer Research
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sapi, E.
Right arrow Articles by Kacinski, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sapi, E.
Right arrow Articles by Kacinski, B. M.
[Cancer Research 59, 5578-5585, November 1, 1999]
© 1999 American Association for Cancer Research

Molecular Biology and Genetics

Effect of All-trans-Retinoic Acid on c-fms Proto-oncogene [Colony-stimulating Factor 1 (CSF-1) Receptor] Expression and CSF-1-induced Invasion and Anchorage-independent Growth of Human Breast Carcinoma Cells1

Eva Sapi2, Maryann B. Flick, Karrie Tartaro, Susan Kim, Yelena Rakhlin, Sofya Rodov and Barry M. Kacinski

Departments of Therapeutic Radiology [E. S., M. B. F., K. T., S. K., Y. R., S. R., B. M. K.], Obstetrics & Gynecology [B. M. K.], and Dermatology [B. M. K.], Yale University School of Medicine, New Haven, Connecticut 06510-8040

Abnormal expression of c-fms proto-oncogene, which encodes for the macrophage colony-stimulating factor-1 (CSF-1) receptor, has been observed in a variety of carcinomas of epithelial origin, including those of the breast. Here, we have investigated the effect of retinoic acid (RA), an important regulator of normal differentiation of mammary epithelial tissues, on the expression of the c-fms gene and CSF-1/CSF-1 receptor-induced invasion and anchorage-independent growth in breast carcinoma cells. We have demonstrated that all-trans-RA (atRA) significantly increases levels of c-fms transcripts in the estrogen receptor-negative but RA receptor {alpha}-positive breast carcinoma cell lines BT20 and SKBR3. The atRA-induced increase in fms transcript levels was completely abolished by RO41-5253, a synthetic RA receptor {alpha} antagonist. Our results indicate that atRA could enhance fms expression by up-regulating the activity of the first promoter of the fms gene. DNase I protection, mobility shift, and mutational analysis revealed that a potential activator protein 1 (AP-1) site in the first fms promoter sequence could mediate the observed atRA effect on fms transcription. Our results also showed that atRA, by itself and in the presence of CSF-1, can increase the ability of breast carcinoma cells to invade in vitro. Furthermore, we demonstrated that atRA is able to abolish the CSF-1-induced increase in anchorage-independent growth of breast carcinoma cells without affecting the anchorage-dependent growth. In summary, our findings suggest that retinoids may play conflicting roles throughout breast cancer progression, depending on the stage of cancer development. Although retinoids might suppress growth at the early stages of tumor formation, they might promote malignant transformation at later stages by stimulating the invasive capacity of certain cell variants in the breast tmor population.




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Mathas, S. Kreher, K. J. Meaburn, K. Johrens, B. Lamprecht, C. Assaf, W. Sterry, M. E. Kadin, M. Daibata, S. Joos, et al.
Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma
PNAS, April 7, 2009; 106(14): 5831 - 5836.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
A. B. Alvero, D. A. Fishman, M. B. Qumsiyeh, M. Garg, B. M. Kacinski, and E. Sapi
Telomerase Prolongs the Lifespan of Normal Human Ovarian Surface Epithelial Cells Without Inducing Neoplastic Phenotype
Reproductive Sciences, December 1, 2004; 11(8): 553 - 561.
[Abstract] [PDF]

Home page
 BloodHome page
M. Witcher, H. Y. Shiu, Q. Guo, and W. H. Miller Jr
Combination of retinoic acid and tumor necrosis factor overcomes the maturation block in a variety of retinoic acid-resistant acute promyelocytic leukemia cells
Blood, November 15, 2004; 104(10): 3335 - 3342.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. A. Antonyak, A. M. Miller, J. M. Jansen, J. E. Boehm, C. E. Balkman, J. J. Wakshlag, R. L. Page, and R. A. Cerione
Augmentation of Tissue Transglutaminase Expression and Activation by Epidermal Growth Factor Inhibit Doxorubicin-induced Apoptosis in Human Breast Cancer Cells
J. Biol. Chem., October 1, 2004; 279(40): 41461 - 41467.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
B. R. Haugen, L. L. Larson, U. Pugazhenthi, W. R. Hays, J. P. Klopper, C. A. Kramer, and V. Sharma
Retinoic Acid and Retinoid X Receptors Are Differentially Expressed in Thyroid Cancer and Thyroid Carcinoma Cell Lines and Predict Response to Treatment with Retinoids
J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 272 - 280.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
E. Sapi
The Role of CSF-1 in Normal Physiology of Mammary Gland and Breast Cancer: An Update
Experimental Biology and Medicine, January 1, 2004; 229(1): 1 - 11.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Shaw, M. Elholm, and N. Noy
Retinoic Acid Is a High Affinity Selective Ligand for the Peroxisome Proliferator-activated Receptor {beta}/{delta}
J. Biol. Chem., October 24, 2003; 278(43): 41589 - 41592.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Manor, E. N. Shmidt, A. Budhu, A. Flesken-Nikitin, M. Zgola, R. Page, A. Yu. Nikitin, and N. Noy
Mammary Carcinoma Suppression by Cellular Retinoic Acid Binding Protein-II
Cancer Res., August 1, 2003; 63(15): 4426 - 4433.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Aharinejad, D. Abraham, P. Paulus, H. Abri, M. Hofmann, K. Grossschmidt, R. Schafer, E. R. Stanley, and R. Hofbauer
Colony-stimulating Factor-1 Antisense Treatment Suppresses Growth of Human Tumor Xenografts in Mice
Cancer Res., September 15, 2002; 62(18): 5317 - 5324.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Muller, S. Kietz, J.-A. Gustafsson, and A. Strom
The Anti-estrogenic Effect of All-trans-retinoic Acid on the Breast Cancer Cell Line MCF-7 Is Dependent on HES-1 Expression
J. Biol. Chem., August 2, 2002; 277(32): 28376 - 28379.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Dong, E. Loukinova, Z. Chen, L. Gangi, T. I. Chanturita, E. T. Liu, and C. Van Waes
Molecular Profiling of Transformed and Metastatic Murine Squamous Carcinoma Cells by Differential Display and cDNA Microarray Reveals Altered Expression of Multiple Genes Related to Growth, Apoptosis, Angiogenesis, and the NF-{{kappa}}B Signal Pathway
Cancer Res., June 1, 2001; 61(12): 4797 - 4808.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.